Collegium Pharmaceutical ...

NASDAQ: COLL · Real-Time Price · USD
37.71
0.55 (1.48%)
At close: Aug 15, 2025, 3:59 PM
37.74
0.08%
After-hours: Aug 15, 2025, 04:34 PM EDT

Collegium Pharmaceutical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
2.42M 12.54M 9.34M 19.61M 27.71M 31.94M 20.63M 13.01M -17.43M -7.2M 457K -5.19M -13.07M -25.03M 8.05M 72.84M 15.66M
Depreciation & Amortization
56.56M 56.51M 37.28M 35.47M 35.43M 35.46M 37.15M 38.36M 38.28M 43.1M 38.04M 38.16M 19.64M 17.22M 17.24M 17.22M 17.23M
Stock-Based Compensation
11.52M 7.6M 7.32M 10.01M 7.47M 7M 7.03M 7.07M 6.04M 5.67M 5.38M 5.69M 6.13M 4.91M 5.95M 6.52M 6.88M
Other Working Capital
-27.8M 13.42M 6.98M 7.14M -8.97M -11.18M 30.12M 21.92M -17.1M -2.74M -21.81M 14.08M -28.03M 13.76M 42.03M -3.12M -8.54M
Other Non-Cash Items
12.66M 1.35M -62.03M 98.34M 76.33M 1.37M 1.51M 2.06M 25.69M 2.28M 2.38M 2.79M 1.07M 777K 837K 884K 926K
Deferred Income Tax
-539K -10.16M -8.73M -3.51M -4.41M -338K -1.13M -636K -46K -1.08M 2.1M -3.37M -6.04M -15.02M -377K -62.65M n/a
Change in Working Capital
-15.7M 16.81M 7.83M -2.22M -5.62M -2.1M 8.83M 39.87M -24.86M 23.55M -5.58M 2.37M -33.05M 53.34M -14.44M -5.28M -20.13M
Operating Cash Flow
55.4M 84.64M -9M 67.4M 61.94M 73.34M 74.02M 99.72M 27.67M 66.33M 42.77M 40.45M -25.32M 36.2M 17.25M 29.54M 20.57M
Capital Expenditures
-798K -570K -244K -270K -568K -164K -65K -56K -176K -940K -113K -461K -108K -515K -276K -725K -428K
Cash Acquisitions
n/a n/a n/a n/a n/a -35.66M -6M n/a n/a n/a n/a n/a -572.07M n/a n/a n/a n/a
Purchase of Investments
-25.89M -27.17M -10.6M -34.29M -39.11M -40.93M -9.76M -41.66M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
17.01M 15.98M 29.42M 25.66M 21.55M 16M 6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -267.54M n/a -17.56M 35.66M 6M -41.66M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-9.68M -11.76M -248.96M -8.91M -18.13M -25.1M -3.82M -41.72M -176K -940K -113K -461K -572.18M -515K -276K -725K -428K
Debt Repayment
-16.15M -16.15M 148.55M -79.05M -45.83M -45.83M -45.83M -46.27M 72.02M -25M -25M -25M 517.68M -12.5M -12.5M -12.5M -12.5M
Common Stock Repurchased
n/a -25.02M 48.7M -35M -12.87M -25M -50M -220K -7.74M -7.64M -6.42M n/a 203K -32.34M -15.52M -421K -3.51M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-11.15M -279K 478K -5.88M -8.31M 3.01M 421K 1.03M -3.72M 6.82M -106K -511K 82K 2.34M -220K 3.67M 1.03M
Financial Cash Flow
-25.24M -41.28M 149.03M -114.21M -54.15M -67.83M -95.41M -45.24M 68.3M -25.82M -31.25M -23.97M 517.76M -42.5M -26.51M -8.83M -11.47M
Net Cash Flow
20.48M 31.61M -107.89M -55.72M -10.34M -19.59M -25.22M 12.77M 95.79M 39.56M 11.4M 16.02M -79.73M -6.82M -9.53M 19.98M 8.67M
Free Cash Flow
54.6M 84.07M -9.24M 67.13M 61.37M 73.17M 73.95M 99.67M 27.5M 65.39M 42.66M 39.99M -25.42M 35.68M 16.98M 28.81M 20.14M